Black Diamond Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $4,894 |
Gross Profit | -86 | -86 | -86 | 4,808 |
EBITDA | -18,044 | -22,044 | -20,160 | -20,769 |
EBIT | -18,130 | -22,130 | -20,246 | -20,855 |
Net Income | -15,557 | -19,909 | -18,225 | -19,408 |
Net Change In Cash | 0 | 0 | 0 | 4,894 |
Free Cash Flow | -11,323 | -14,726 | -21,199 | -13,923 |
Cash | 23,425 | 32,811 | 25,422 | 56,221 |
Basic Shares | 56,507 | 55,155 | 51,808 | 51,637 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -437 | -3,238 | -2,217 | -600 |
EBITDA | -86,023 | -92,320 | -126,667 | -66,654 |
EBIT | -86,460 | -95,558 | -128,884 | -67,254 |
Net Income | -82,442 | -84,520 | -123,203 | -65,479 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -31,539 | 31,194 | -118,893 | |
Free Cash Flow | -66,750 | -85,274 | -102,858 | -52,288 |
Cash | 56,221 | 34,315 | 65,799 | 34,605 |
Basic Shares | 43,954 | 36,325 | 36,189 | 32,907 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.27 |
2024-06-30 | -$0.36 |
2024-03-31 | -$0.35 |
2023-12-31 | -$0.34 |
